In conclusion, compared with voglibose, sitagliptin added to combined insulin and metformin therapy can achieve a significantly better effect on lowering HbA1c and FPG and shows excellent safety for newly diagnosed T2DM patients with highly elevated blood glucose. The gene discussed is INS; the disease is type 2 diabetes mellitus.